ATAI logo

Atai Life Sciences NV (ATAI) Cash From Operations

Annual CFO

-$84.12 M
+$20.35 M+19.48%

December 31, 2023

Summary

Performance

1-Year Change

+19.48%

3-Year Change

-305.08%

5-Year Change

-77.87%

15-Year Change

-693.58%

ATAI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.82%
ATAI annual cash flow from operations is higher than 16.82% of companies in Healthcare sector

High & Low

All-time High

$14.17 M
ATAI annual cash flow from operations is currently -693.58% below its historical high of $14.17 million

3-Year Low

-$104.47 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ATAI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
ATAI next annual earnings announcement is scheduled for May 15, 2025

OtherATAIcash flowmetrics:

Annual CFI

-$53.30 M
ATAI annual cash flow from investing activities is -$53.30 million

Annual CFF

-$8.36 M
ATAI annual cash flow from financing activities is -$8.36 million

Annual FCF

-$84.71 M
ATAI annual free cash flow is -$84.71 million

Annual CAPEX

$590.00 K
ATAI annual capital expenditures is $590.00 thousand

Quarterly CFO

-$19.34 M
-$3.11 M-19.18%

September 30, 2024

Summary

Performance

3-Month Change

-19.18%

1-Year Change

-4.94%

3-Year Change

+19.37%

5-Year Change

+19.37%

ATAI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

20.52%
ATAI quarterly cash flow from operations is higher than 20.52% of companies in Healthcare sector

High & Low

All-time High

$1.90 M
ATAI quarterly cash flow from operations is currently -1119.56% below its historical high of $1.90 million

3-Year Low

-$30.50 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATAI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
ATAI next earnings announcement is scheduled for May 15, 2025

OtherATAIcash flowmetrics:

Quarterly CFI

$24.84 M
ATAI quarterly cash flow from investing activities is $24.84 million

Quarterly CFF

$4.89 M
ATAI quarterly cash flow from financing activities is $4.89 million

Quarterly FCF

-$19.34 M
ATAI quarterly free cash flow is -$19.34 million

Quarterly CAPEX

$1000.00
ATAI quarterly capital expenditures is $1000.00

TTM CFO

-$80.10 M
-$910.00 K-1.15%

September 30, 2024

Summary

Performance

3-Month Change

-1.15%

1-Year Change

+13.55%

3-Year Change

-13.29%

5-Year Change

-13.29%

ATAI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.21%
ATAI TTM cash flow from operations is higher than 19.21% of companies in Healthcare sector

High & Low

All-time High

-$3.89 M

3-Year Low

-$104.47 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATAI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
ATAI next earnings announcement is scheduled for May 15, 2025

OtherATAIcash flowmetrics:

TTM CFI

$51.79 M
ATAI TTM cash flow from investing activities is $51.79 million

TTM CFF

-$3.24 M
ATAI TTM cash flow from financing activities is -$3.24 million

TTM FCF

-$80.13 M
ATAI TTM free cash flow is -$80.13 million

TTM CAPEX

$23.00 K
ATAI TTM capital expenditures is $23.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ATAI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.5%-4.9%+13.6%
3 y3 years-305.1%+19.4%-13.3%
5 y5 years-77.9%+19.4%-13.3%

ATAI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-33.0%+19.5%-19.2%+36.6%-26.6%+23.3%
5 y5-year-972.1%+19.5%-1119.6%+36.6%-1959.8%+23.3%
alltimeall time-693.6%+19.5%-1119.6%+36.6%-1959.8%+23.3%

Atai Life Sciences NV Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$19.34 M(+19.2%)
-$80.10 M(+1.1%)
Jun 2024
-
-$16.23 M(-28.1%)
-$79.19 M(-7.5%)
Mar 2024
-
-$22.57 M(+2.8%)
-$85.58 M(+1.7%)
Dec 2023
-$84.12 M(-19.5%)
-$21.96 M(+19.2%)
-$84.12 M(-9.2%)
Sep 2023
-
-$18.43 M(-18.5%)
-$92.66 M(-9.4%)
Jun 2023
-
-$22.61 M(+7.1%)
-$102.28 M(+0.7%)
Mar 2023
-
-$21.11 M(-30.8%)
-$101.59 M(-2.8%)
Dec 2022
-$104.47 M(+65.2%)
-$30.50 M(+8.8%)
-$104.47 M(+10.6%)
Sep 2022
-
-$28.05 M(+27.9%)
-$94.47 M(-0.1%)
Jun 2022
-
-$21.93 M(-8.6%)
-$94.54 M(+33.7%)
Mar 2022
-
-$23.99 M(+17.0%)
-$70.71 M(+11.8%)
Dec 2021
-$63.25 M(+204.6%)
-$20.51 M(-27.0%)
-$63.25 M(+29.2%)
Sep 2021
-
-$28.11 M(-1581.8%)
-$48.95 M(+86.2%)
Jun 2021
-
$1.90 M(-111.5%)
-$26.29 M(-21.3%)
Mar 2021
-
-$16.52 M(+165.9%)
-$33.40 M(+60.8%)
Dec 2020
-$20.77 M
-$6.21 M(+14.1%)
-$20.77 M(+42.7%)
Sep 2020
-
-$5.45 M(+4.4%)
-$14.55 M(+59.8%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$5.22 M(+34.2%)
-$9.11 M(+134.2%)
Mar 2020
-
-$3.89 M
-$3.89 M
Dec 2019
-$7.85 M(-83.4%)
-
-
Dec 2018
-$47.29 M(-433.7%)
-
-
Dec 2017
$14.17 M(+55.3%)
-
-
Mar 2017
$9.13 M(-10.0%)
-
-
Mar 2016
$10.14 M(+37.1%)
-
-
Mar 2015
$7.40 M(+21.2%)
-
-
Mar 2014
$6.10 M(-43.3%)
-
-
Mar 2013
$10.76 M(+16.1%)
-
-
Mar 2012
$9.27 M(+0.4%)
-
-
Mar 2011
$9.23 M(-325.3%)
-
-
Mar 2010
-$4.10 M(-189.1%)
-
-
Mar 2009
$4.60 M(>+9900.0%)
-
-
Mar 2008
$40.90 K(-102.0%)
-
-
Mar 2007
-$2.10 M(+2.9%)
-
-
Mar 2006
-$2.04 M
-
-

FAQ

  • What is Atai Life Sciences NV annual cash flow from operations?
  • What is the all time high annual CFO for Atai Life Sciences NV?
  • What is Atai Life Sciences NV annual CFO year-on-year change?
  • What is Atai Life Sciences NV quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Atai Life Sciences NV?
  • What is Atai Life Sciences NV quarterly CFO year-on-year change?
  • What is Atai Life Sciences NV TTM cash flow from operations?
  • What is the all time high TTM CFO for Atai Life Sciences NV?
  • What is Atai Life Sciences NV TTM CFO year-on-year change?

What is Atai Life Sciences NV annual cash flow from operations?

The current annual CFO of ATAI is -$84.12 M

What is the all time high annual CFO for Atai Life Sciences NV?

Atai Life Sciences NV all-time high annual cash flow from operations is $14.17 M

What is Atai Life Sciences NV annual CFO year-on-year change?

Over the past year, ATAI annual cash flow from operations has changed by +$20.35 M (+19.48%)

What is Atai Life Sciences NV quarterly cash flow from operations?

The current quarterly CFO of ATAI is -$19.34 M

What is the all time high quarterly CFO for Atai Life Sciences NV?

Atai Life Sciences NV all-time high quarterly cash flow from operations is $1.90 M

What is Atai Life Sciences NV quarterly CFO year-on-year change?

Over the past year, ATAI quarterly cash flow from operations has changed by -$910.00 K (-4.94%)

What is Atai Life Sciences NV TTM cash flow from operations?

The current TTM CFO of ATAI is -$80.10 M

What is the all time high TTM CFO for Atai Life Sciences NV?

Atai Life Sciences NV all-time high TTM cash flow from operations is -$3.89 M

What is Atai Life Sciences NV TTM CFO year-on-year change?

Over the past year, ATAI TTM cash flow from operations has changed by +$12.56 M (+13.55%)